US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 948.400
  • +14.260+1.53%
Close Jul 12 16:00 ET
  • 949.000
  • +0.600+0.06%
Post 19:57 ET
901.36BMarket Cap139.68P/E (TTM)

Eli Lilly and Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Eli Lilly and Co Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

Apr 30, 2024

Revenue(YoY)

8.77B

+25.98%
EPS(YoY)

2.48

+66.44%
Analyst Rating

Strong Buy

Jul 13, 2024

Eli Lilly and Co Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 11.334B--
Aug 8, 20242024/Q2-- / 9.998B--
Apr 30, 20242024/Q18.768B / 8.930B--
Feb 6, 20242023/Q49.353B / 8.971B--
Nov 2, 20232023/Q39.499B / 8.965B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 11.334B--
Aug 8, 20242024/Q2-- / 9.998B--
Apr 30, 20242024/Q18.768B / 8.930B--
Feb 6, 20242023/Q49.353B / 8.971B--
Nov 2, 20232023/Q39.499B / 8.965B--

Unlock Free Earnings Estimates

Eli Lilly and Co Earnings Reports

  • Eli Lilly and Co | 10-Q: Quarterly report

    Apr 30 12:09 ET

  • Eli Lilly and Co | 10-K: Annual report

    Feb 21 11:46 ET

  • Eli Lilly and Co | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 11:21 ET

  • Eli Lilly and Co | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 13:23 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 13, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Weight Loss Drugs
    Weight Loss Drugs
    Intraday+1.52%
    Trump-Win Beneficial Stocks
    Trump-Win Beneficial Stocks
    Intraday+0.20%